DDReg Pharma

DELIVER BETTER DATA TO ENSURE FASTER APPROVAL
DDReg Pharma

DDReg attends CPHI Barcelona

CPHI Barcelona was held on 24th to 26th of October 2023 and brought together industry leader, experts, and key stakeholders under one roof to discuss some of the key innovative trends in the industry. DDReg was among the industry experts to have attended the conference and engage insightful meetings and networking opportunities. CPHI Barcelona is a known pharmaceutical event that attracts about 45,000 participants from over 170 countries every year. It showcases a range of more than 1,800 exhibitors.

Pharma Tech Innovation: Technology-enabled innovation has indeed revolutionized the pharmaceutical industry and continues to do so as it ushers in a new era of drug development. Regulatory affairs traditionally involved extensive paperwork, manual processes, and lengthy approval timelines. However, advancements in technology-based solutions has streamlined critical processes in this field.

CPHI Pharma Awards: DDReg was nominated under the ‘Regulatory’ category for its entry on “Technology Enabled Regulatory Services through Vitalic®”. This was a milestone achievement for the organization as it showcased its dedication to maintaining standards and fostering innovation in the pharmaceutical industry. It was an honour to be acknowledged as a finalist among 203 entries from all across the globe.

Indeed, DDReg’s recognition in the ‘Regulatory’ category for its submission highlights their unique method of tackling regulatory obstacles. Vitalic® is a cloud-based platform that automates and streamlines regulatory processes. This pioneering technology brings efficiency to submissions by reducing time-to-market cost, resource utilisation and the risk of non-compliance. It emphasises the significance of technology-enabled solutions in simplifying activities within the pharmaceutical sector

Attending the CPHI Pharma Awards was truly inspiring especially to see the innovative technology-based solutions and ideas presented at the event. DDReg’s commitment for innovation compels us to welcome concepts and pursue avenues for growth, and are determined to continue its journey of excellence and innovation in the pharmaceutical industry.

Read about DDReg’s nomination for CPHI Pharma Awards here: DDReg Shortlisted for ‘Regulatory’ by CPHI Pharma Awards 2023 – DDReg Pharma